RecruitingProstate Cancer Screening
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Eligible age
50–70 yrs
Accepts
Men
Locations
2 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Sponsor: University of Alberta
You may qualify if…
- ✓ 1. Male sex;
- ✓ 2. Age 50-70;
- ✓ 3. PSA 3-20 and/or abnormal DRE;
- ✓ 4. Biopsy naïve.
You may not qualify if…
- ✕ 1. Prior personal history of prostate cancer;
- ✕ 2. Prior prostate imaging using microUS or MRI;
- ✕ 3. Contraindication to microUS or MRI;
- ✕ 4. Testosterone replacement therapy within last 12 months; or
- ✕ 5. Androgen deprivation therapy within last 12 months.
Where it's recruiting
California
Los Angeles
Texas
Dallas
Source: ClinicalTrials.gov · NCT06626022 · last updated 2026-06-04